News from the world of medicine - Germany's Boehringer Ingelheim said today that it will discontinue development of its "female desire drug" flibanserin for the treatment of Hypoactive Sexual Desire Disorder because of FDA requests for further support of the efficacy and safety profile of the drug. According to Wikipedia, Hypoactive Sexual Desire Disorder is characterized as a lack or absence of sexual fantasies and desire for sexual activity.
Is there some sort of colored ribbon for that?
Blue. In honor of the partners of the women.
ReplyDeleteThose partners can be indentified by gold bands on the ring fingers of their left hand.
ReplyDelete